Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Vernakalant IV regulatory update

The partners said the PDUFA date for an NDA for vernakalant IV for the acute

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE